CIK 0001140859 · Large accelerated filer
Cencora, Inc.
Sign in to watch- Ticker
- COR
- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233079390
- Phone
- 610-727-7000
- Business address
- 1 WEST FIRST AVENUE, CONSHOHOCKEN, PA, 19428
- Former names
- AMERISOURCEBERGEN CORP, AMERISOURCE BERGEN CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,020,270
- in 5 filings, $946K under 10b5-1 plans
Net −$5,020,270. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-18 | Mauch Robert P. President & CEO | Sale 10b5-1 | −3,226 | $260.93 | $842K | 51,070 |
| 2025-03-18 | Mauch Robert P. President & CEO | Sale 10b5-1 | −1,744 | $260.93 | $455K | 49,326 |
| 2025-03-18 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,226 | 38,702 | ||
| 2025-03-10 | Krikorian Lazarus SVP & Chief Accounting Officer | Sale | −2,000 | $260.06 | $520K | 20,154 |
| 2025-03-06 | Kim Lorence H. Director | Grant or award | +789 | 3,524 | ||
| 2025-03-06 | Baumann Werner Director | Grant or award | +789 | 2,771 | ||
| 2025-03-06 | Clyburn Frank Director | Grant or award | +789 | 1,157 | ||
| 2025-03-06 | GREENBERG LON R Director | Grant or award | +789 | 20,851 | ||
| 2025-03-06 | Miller Redonda Director | Grant or award | +789 | 3,194 | ||
| 2025-03-06 | NALLY DENNIS M Director | Grant or award | +789 | 13,130 | ||
| 2025-03-06 | Tyler Lauren M Director | Grant or award | +789 | 2,771 | ||
| 2025-03-06 | DURCAN DERMOT MARK Director | Grant or award | +986 | 22,862 | ||
| 2025-03-03 | Mauch Robert P. President & CEO | Sale 10b5-1 | −1,744 | $255.00 | $445K | 51,070 |
| 2025-03-03 | Mauch Robert P. President & CEO | Option exercise 10b5-1 | +3,226 | $86.09 | $278K | 54,296 |
| 2025-03-03 | Mauch Robert P. President & CEO | Sale 10b5-1 | −3,226 | $255.00 | $823K | 51,070 |
| 2025-03-03 | Mauch Robert P. President & CEO | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −3,226 | 41,928 | ||
| 2025-02-27 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −2,000 | $251.08 | $502K | 319,912.67 |
| 2025-02-27 | COLLIS STEVEN H Executive Chairman | Option exercise 10b5-1 | +12,579 | $86.09 | $1.1M | 332,491.67 |
| 2025-02-27 | COLLIS STEVEN H Executive Chairman | Sale 10b5-1 | −12,579 | $251.08 | $3.2M | 319,912.67 |
| 2025-02-27 | COLLIS STEVEN H Executive Chairman | Option exercise · Non-qualified Stock Option (Right to Buy) 10b5-1 | −12,579 | 163,520 |
Page 12 of 40 · 797 trades